October saw the launch of a new National Academy for Social Prescribing (NASP), to champion social prescribing and the work of local communities in connecting people for wellbeing. Its objectives include exploring new ways of sourcing statutory and non-statutory funding and brokering relationships between different sectors. Given the prevalence of MSK conditions, it is important that social prescribing has something to offer for MSK.
The NHS Long Term Plan includes plans to recruit over 1,000 trained social prescribing link workers by 2020 to 2021, with the aim of 900,000 people being referred to social prescribing schemes by then.…
Read more of this article
ARMA joins Public Health England and the Centre for Ageing Better to make England the best place to grow old, because musculoskeletal health is vital to healthy ageing.
Guest blog by Amanda Woolley, Policy and Implementation Lead for the Elective Care Transformation Programme at NHS England and NHS Improvement
In September, Public Health England published a report on their review of the scale, distribution and causes of prescription drug dependence, and what might be done to address it. This included findings on opioid use for non cancer pain. The report made recommendations for action to reduce the problems caused by dependency and stated that effective, personalised care should include shared decision-making with patients and regular reviews of whether treatment is working.
by Simon Chapman, Deputy Director, Personalised Care Group, NHS England.
by Duleep Allirajah, Assistant Director of Policy and Campaigns, RCGP
by Jill Hamilton, Professional Engagement Manager, National Ankylosing Spondylitis Society